In addition, administration of 1,25(OH)2D3 or AGP after the induction of UUO or other kidney disease model such as 5/6 nephrectomy will further validate the effects of 1,25(OH)2D3 or AGP. This evidence concerns the gene ATP5MK and kidney disorder.